发明名称 |
NKT cell-activating agents containing alpha-glycosylceramides |
摘要 |
<p>An objective of the present invention is to provide NKT cell-activating agents, therapeutic agents for autoimmune diseases (for example, systemic lupus erythematosus, systemic sclerosis, ulcerative colitis, encephalomyelitis, multiple sclerosis and human type I diabetes), and abortifacients. The medicinal compositions according to the present invention comprise α-glycosylceramides of the following formula (I), or a salt or a solvate thereof as an active ingredient.
<Chemistry id="chema01" num="0001"><Image id="ia01" he="61" wi="95" file="IMGA0001.TIF" imgContent="chem" imgFormat="TIFF" /></Chemistry></p> |
申请公布号 |
EP1520583(A3) |
申请公布日期 |
2006.01.25 |
申请号 |
EP20040030878 |
申请日期 |
1998.04.10 |
申请人 |
KIRIN BEER KABUSHIKI KAISHA |
发明人 |
TANIGUCHI, MASARU;KAWANO, TETSU;KOEZUKA, YASUHIKO |
分类号 |
A61K31/70;A61K31/7028;A61K31/7032;A61K31/715;A61K35/14;A61P15/06;C07H15/04;C12N5/06;C12N5/08 |
主分类号 |
A61K31/70 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|